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TO THE EDITOR
Fogo selvagem (FS) is an endemic form
of pemphigus foliaceus, which is pre-
valent in certain regions of Brazil (Diaz
et al., 1989). Genetic and environ-
mental factors such as insect bites may
contribute to the development of FS
(Diaz et al., 1989; Moraes et al., 1997;
Aoki et al., 2004). Blister formation in FS
is mediated by predominantly IgG4 anti-
desmoglein 1 (Dsg1) antibodies (Rock
et al., 1989), which are predictors of FS
(Qaqish et al., 2009). Our recent studies
demonstrate that FS IgG4 antibodies
cross-react with LJM11, a salivary pro-
tein from sand fly Lutzomyia longipalpis
(Qian et al., 2012), suggesting that sand
fly bites may deliver the antigen(s) that
have a role in driving the development
of these IgG4 autoantibodies in FS.
The concomitant development of IgE
and IgG4 has been well documented in
allergy (Lichtenstein et al., 1968; Muller,
2005). In addition, insect bites are
known to induce IgE responses. IgE
response in pemphigus vulgaris and FS
has been described by Nagel et al.
(2009) and us (Qian et al., 2011,
2012). We have demonstrated that FS
patients have significantly higher IgG4
and IgE against sand fly salivary gland
antigens (SGLL) and monoclonal IgG4
autoantibodies derived from FS patients
cross-react with LJM11, a major
immunogenic component from SGLL
(Qian et al., 2012). In this study, we
seek to determine whether IgE
antibodies to either autoantigen (Dsg1)
and/or environmental antigen (LJM11)
are present among individuals living in
FS endemic regions. All serum samples
from controls and patients in this
investigation were obtained from
individuals studied during the last 25
years and kept in a bank of sera at
the University of North Carolina
Dermatology Research Laboratories.
These studies are approved by the
institutional review boards from the
University of North Carolina, Chapel
Hill, and the University of Sao Paulo,
Sao Paulo, Brazil. Randomly selected
serum samples (n¼30) from FS patients,
as well as serum samples of healthy
control (HC) individuals from FS
endemic region (n¼32), Limao VerdeAccepted article preview online 6 October 2014; published online 6 November 2014
Abbreviations: Dsg1, desmoglein 1; FS, fogo selvagem; HC, healthy control; LV, Limao Verde in Brazil;
RLUs, relative light units; SGLL, salivary gland antigens from sand fly (Lutzomyia longipalpis)
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in Brazil (HC-LV), and non-FS endemic
region, United States (n¼32; HC-US),
were tested by ELISA for their reactivity
with Dsg1, LJM11, and LJL143, which is
another major component of SGLL. As
expected, FS patients have signifi-
cantly higher levels of IgG4 anti-Dsg1
autoantibodies compared with HC-LV
and HC-US (Figure 1a, left panel).
Similarly, FS patients also have signifi-
cantly higher IgG4 anti-LJM11 antibo-
dies compared with HC-LV and HC-US
groups (Figure 1a, middle panel). There
is no significant difference between the
levels of anti-LJL143 IgG4 antibodies in
the sera of FS patients and the two
control groups (Figure 1a, right panel),
suggesting that LJM11 is the main
component from SGLL recognized by
IgG4 antibodies from FS patients.
Because of the close association of the
IgE and IgG4 development and our
previous finding that FS patients have
significant levels of IgE and IgG4 anti-
SGLL (Qian et al., 2012), it is expected
that FS patients may also have higher IgE
anti-Dsg1 and anti-LJM11 compared
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Figure 1. Fogo selvagem (FS) patients have significantly higher IgG4 (a) and IgE (b) anti-Dsg1 and anti-LJM11 antibodies compared with normal control
individuals from FS and non-FS endemic regions. Anti-desmoglein 1 (anti-Dsg1) (a) and anti-LJM11 (b) ELISA were conducted as described (Qian et al., 2007;
2011, 2012) using SuperSignal ELISA Pico (for IgG4) and Femto (for IgE; Thermo Fisher, Rockford, IL) as substrate. The relative light units were measured by LMax II
384 Luminometer (Molecular Devices, Sunnyvale, CA). Horseradish peroxidase conjugated mouse anti-human IgE (clone HP6029, Hamilton and Morrison, 1993)
(SouthernBiotech, Birmingham, AL) was used as secondary antibody for IgE ELISA. The levels of IgG4 or IgE anti-Dsg1 or anti-LJM11 are expressed as index values
(Amagai et al., 1999; Qaqish et al., 2009). The horizontal lines within the box plots indicate the median values. The P-values of the comparisons between each
group pair are indicated. Statistical significance between any two groups is assessed by the t-test. Significant difference is marked by *(Po0.05) or **(Po0.01), and
P-values are indicated.
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Figure 2. IgE antibodies among individuals before or after their onset of fogo selvagem (FS). (a) Anti-desmoglein 1 (anti-Dsg1) and anti-LJM11 IgE levels among
pre-FS and post-FS individuals were determined by ELISA and compared with IgE and IgG4 anti-Dsg1 and LJM11 of healthy controls (HC) from both FS endemic
region (Limao Verde in Brazil, LV) and non-FS endemic region (US). (b) The binding of serum IgE antibodies from pre-FS and post-FS individuals to LJM11 is
inhibited by recombinant human Dsg1. IgE anti-LJM11 ELISA is conducted in the presence and absence of Dsg1. The percentage of inhibition is determined by the
reduction in relative light units (RLUs) in the presence of Dsg1 (50mg ml1) divided by RLUs without Dsg1 for each serum sample. Statistical significance between
any two groups is assessed by the t-test. Significant difference is marked by *(Po0.05) or **(Po0.01), and P-values are indicated.
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with HC-LV and HC-US. As shown in
Figure 1b, FS patients have significantly
higher IgE anti-Dsg1 (Figure 1b, left
panel) as we previously reported (Qian
et al., 2011, 2012) and also have
significantly higher levels of IgE anti-
LJM11 antibodies (Figure 1b, middle
panel) compared with both HC-LV and
HC-US. Importantly, HC-LV sera have
higher levels of IgE anti-LJM11
antibodies compared with those from
HC-US (Figure 1b, middle panel).
The anti-LJL143 IgE levels are overall
generally much lower (about 10 times
lower) in FS, HC-LV, and HC-US groups
as compared with anti-LJM11 IgE levels
in the same group (Figure 1b, middle
and right panel). These findings suggest
that the FS endemic area of LV where
the sera of FS and HC-LV originated
from, and where bites by Lutzomya
longipalpis are prevalent, may harbor
environmental factors that direct the
development of these antibodies in FS
endemic regions.
Our findings that LV inhabitants and
FS patients show significant levels of IgE
anti-LJM11 antibodies suggest that FS
patients during the pre-clinical stage of
the disease (pre-FS) may also exhibit
elevated levels of these IgE antibodies.
It is known that pre-FS would eventually
develop pathogenic IgG4 autoantibo-
dies and clinical FS (post-FS) (Qaqish
et al., 2009), and IgG4 antibody
development lags behind the IgE
response. Hence, individuals at risk to
develop FS may develop IgE and IgG4
responses when exposed to LJM11
during the repeated bites of sand flies.
To test this hypothesis, 12 FS patients
whose serum samples were collected
prior to the onset of clinical FS (1–4
years) and after their onset of FS were
studied for anti-Dsg1 and anti-LJM11 IgE
activity. The HC-LV and HC-US were
also included as controls. As shown in
Figure 2a (left panel), pre-FS and post-FS
individuals exhibit higher levels of IgE
anti-Dsg1 compared with the control
groups. The right panel of Figure 2a
shows that these pre-FS and post-FS
individuals also have significantly
higher levels of IgE anti-LJM11 as com-
pared with HC-LV and HC-US. These
results suggest that the IgE antibodies
against Dsg1 and LJM11 develop before
the onset of FS among susceptible indi-
viduals from this endemic area. In addi-
tion, similar to IgG4 antibodies in FS,
IgE anti-LJM11 and anti-Dsg1 antibodies
from both pre-FS and post-FS are also
cross-reactive, as their IgE binding to
LJM11 can be inhibited by Dsg1 auto-
antigen (Figure 2b). Notably, pre-FS
individuals have significantly lower
levels of IgE anti-Dsg1 compared with
that from post-FS patients (Figure 2a,
left panel), suggesting that anti-LJM11
IgE develops prior to that of IgE
autoantibodies.
Considering that IgG4 and IgE anti-
body responses to allergens are closely
linked, it is likely that the generation of
IgE anti-LJM11, introduced by sand fly
bites, results in the development of IgE
and IgG4 to this antigen that cross-reacts
with Dsg1 and subsequently leads to
clinical FS. The definitive evolution and
association of IgG4 and IgE antibody
responses in FS require further analysis
of the CDR3 sequences of these two
classes of antibody populations. Our
current findings suggest that LJM11
might be the initial target of the IgE
response in FS susceptible individuals;
hence, those individuals with higher
levels of anti-LJM11 IgE may have a
higher risk to develop FS. It may provide
a basis for the possible employment of
IgE as an early predictor of FS.
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